Incidence and mortality of malignant tumours in Serbia: A comparative analysis

D. Miljuš
{"title":"Incidence and mortality of malignant tumours in Serbia: A comparative analysis","authors":"D. Miljuš","doi":"10.5937/gjz2101085m","DOIUrl":null,"url":null,"abstract":"After cardiovascular diseases, malignant tumours are the second leading cause of death across Europe. Given that Europe has a quarter of all cancer cases and less than 10% of the world's population, it is obvious that cancer poses a huge burden in the entire European region. A comparative analysis of the incidence of malignant tumours in Serbia and European countries in 2018 showed that men in Serbia most often suffered from malignant tumours of the prostate, lungs and bronchus, colon and rectum, while in women, malignant tumours were most often localized in the breast, lungs and bronchus, colon and rectum. Women in Europe most often suffered from malignant tumours of the breast, colon and rectum, and lungs and bronchus, while they most often died from the same tumours as the women in our country. Compared to the inhabitants of the European region, the population of Serbia has a higher incidence of morbidity and mortality from all leading cancers; exceptions can be observed in the structure of new patients with malignant prostate tumours, women with newly discovered breast cancers and men who died from liver cancer. For the majority of malignancy sites, the risk of cancer in Serbia is estimated as \"moderate\", and \"low\" for malignant prostate tumours. However, the observed increase in incidence for the most common malignancies could, in the next two decades, bring Serbian citizens into the ranks of European countries with a high risk of disease. Throughout Europe, the burden of cancer puts pressure on national health and social protection systems, state budgets and affects productivity and economic growth. National campaigns for health promotion and prevention of risk factors that are responsible for the occurrence of the most common malignant tumours and other non-communicable diseases, early detection and implementation of screening programs for malignant tumours, are the basis of the cancer control strategy, both in the old continent as a whole, and in Serbia.","PeriodicalId":438201,"journal":{"name":"Glasnik javnog zdravlja","volume":"52 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Glasnik javnog zdravlja","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5937/gjz2101085m","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

After cardiovascular diseases, malignant tumours are the second leading cause of death across Europe. Given that Europe has a quarter of all cancer cases and less than 10% of the world's population, it is obvious that cancer poses a huge burden in the entire European region. A comparative analysis of the incidence of malignant tumours in Serbia and European countries in 2018 showed that men in Serbia most often suffered from malignant tumours of the prostate, lungs and bronchus, colon and rectum, while in women, malignant tumours were most often localized in the breast, lungs and bronchus, colon and rectum. Women in Europe most often suffered from malignant tumours of the breast, colon and rectum, and lungs and bronchus, while they most often died from the same tumours as the women in our country. Compared to the inhabitants of the European region, the population of Serbia has a higher incidence of morbidity and mortality from all leading cancers; exceptions can be observed in the structure of new patients with malignant prostate tumours, women with newly discovered breast cancers and men who died from liver cancer. For the majority of malignancy sites, the risk of cancer in Serbia is estimated as "moderate", and "low" for malignant prostate tumours. However, the observed increase in incidence for the most common malignancies could, in the next two decades, bring Serbian citizens into the ranks of European countries with a high risk of disease. Throughout Europe, the burden of cancer puts pressure on national health and social protection systems, state budgets and affects productivity and economic growth. National campaigns for health promotion and prevention of risk factors that are responsible for the occurrence of the most common malignant tumours and other non-communicable diseases, early detection and implementation of screening programs for malignant tumours, are the basis of the cancer control strategy, both in the old continent as a whole, and in Serbia.
塞尔维亚恶性肿瘤的发病率和死亡率:比较分析
在整个欧洲,恶性肿瘤是仅次于心血管疾病的第二大死因。鉴于欧洲的癌症病例占世界的四分之一,而人口却不到世界的10%,很明显,癌症对整个欧洲地区构成了巨大的负担。2018年塞尔维亚和欧洲国家恶性肿瘤发病率的比较分析显示,塞尔维亚男性最常患前列腺、肺和支气管、结肠和直肠恶性肿瘤,而女性恶性肿瘤最常局限于乳房、肺和支气管、结肠和直肠。欧洲妇女最常患的是乳房、结肠、直肠、肺部和支气管的恶性肿瘤,而她们最常死于与我国妇女相同的肿瘤。与欧洲地区的居民相比,塞尔维亚人口的所有主要癌症发病率和死亡率都较高;在新患恶性前列腺肿瘤的病人、新发现乳腺癌的妇女和死于肝癌的男子的结构中可以观察到例外情况。对于大多数恶性肿瘤,塞尔维亚的癌症风险估计为“中等”,恶性前列腺肿瘤的风险估计为“低”。然而,观察到的最常见恶性肿瘤发病率的增加,可能在今后二十年使塞尔维亚公民进入疾病高风险的欧洲国家行列。在整个欧洲,癌症负担给国家卫生和社会保护系统、国家预算带来压力,并影响生产力和经济增长。促进健康和预防导致最常见恶性肿瘤和其他非传染性疾病发生的危险因素的全国运动、恶性肿瘤的早期发现和筛查方案的实施,是整个旧大陆和塞尔维亚癌症控制战略的基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书